Clin2
NCT03146884Likely a fitRecruiting

Study of autoimmune hepatitis in people living in Switzerland

Hepatitis, AutoimmuneAutoimmune Hepatitis

Part of Digestive system, Immune system & allergy clinical trials.

This study looks at people with autoimmune hepatitis (an immune system condition that attacks the liver). It aims to learn more about the disease by following patients who live in Switzerland.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
500 people
Ages
Any age
Study type
Observational

Who can take part

  • You have been diagnosed with autoimmune hepatitis
  • Your autoimmune hepatitis is type 1 or type 2
  • You currently live in Switzerland

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06078098Recruiting
Autoimmune Hepatitis Database and Biobank Study

This study is building a database and collection of samples from people with autoimmune hepatitis in Italy. It aims to learn more about the disease and improve care.

Monza, MB
NCT05785793Recruiting
Autoimmune hepatitis study for people in China

This study follows people with autoimmune hepatitis (a condition where the immune system attacks the liver) and requires key blood test results at diagnosis. It may help doctors better understand this disease and how it progresses in patients in China.

Shanghai, Shanghai Municipality
NCT07784881Not yet recruiting
Studying immune cells in autoimmune hepatitis

This study is looking at specific immune cells (T cells) in the blood of people with autoimmune hepatitis (AIH) to better understand the disease. If you have untreated AIH and meet certain criteria, you may be able to participate.

Nantes
NCT03569826Recruiting
Study for primary biliary cholangitis and autoimmune hepatitis

This study is for people diagnosed with primary biliary cholangitis or autoimmune hepatitis. It aims to learn more about these autoimmune liver conditions and may help guide better care in the future.

Calgary, Alberta
NCT07644936Not yet recruiting
Understanding autoimmune hepatitis through lipid markers

This study examines the molecular profile of autoimmune hepatitis (a liver condition where the immune system attacks liver cells) using lipid analysis. Researchers hope to better understand the disease and potentially improve diagnosis and treatment in the future.

Castellana Grotte, Bari
NCT06356506Not yet recruiting
Factors of treatment response in autoimmune hepatitis

This study looks at factors that help predict how well people with autoimmune hepatitis respond to treatment. It is for patients who are newly diagnosed or have not had treatment for at least 3 months, and who have had a liver biopsy to confirm the diagnosis.

Beijing

Hear when a new Autoimmune Hepatitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.